论文部分内容阅读
目的:探讨经尿道等离子束切割前列腺治疗良性前列腺增生的安全性与有效性。方法:应用经尿道等离子束治疗良性前列腺增生712例,平均年龄70.6岁,平均前列腺质量52 g;术前、术后行尿流率、残余尿量测定、国际前列腺症状评分(IPSS)及生活质量评分(QOL)并予以比较。结果:本组病例712例,平均年龄70.6岁,手术时间20～120 m in,平均51 m in。切割前列腺组织15～96 g,平均46 g。无电切综合征发生。术后随访1～52个月,平均27.6个月,最大尿流率(Qm ax)由术前的4.7上升至19.1 m l/s;IPSS由术前的26.6分下降至5.8分;QOL评分由术前的5.4分下降至1.7分,3项指标手术前后比较均有显著性差别(P均<0.01)。结论:经尿道等离子束切割前列腺治疗良性前列腺增生是一种安全、有效的手术方式。
Objective: To investigate the safety and efficacy of transurethral plasma-assisted laser ablation of prostate in the treatment of benign prostatic hyperplasia. Methods: A total of 712 benign prostatic hyperplasia patients were treated with transurethral plasmapheresis. The mean age was 70.6 years. The mean prostate mass was 52 g. The preoperative and postoperative urinary flow rate, residual urine volume, International Prostate Symptom Score (IPSS) and quality of life Score (QOL) and compare. Results: The group of 712 patients, mean age 70.6 years, operation time 20 ~ 120 mins, an average of 51 m in. Prostate tissue from 15 to 96 g, an average of 46 g. No cut-off syndrome occurs. The mean flow rate (Qm ax) increased from 4.7 before surgery to 19.1 ml / s in patients who were followed up for 1 to 52 months (mean 27.6 months). The IPSS decreased from 26.6 points to 5.8 points before surgery. The QOL score Before the 5.4 points dropped to 1.7 points, 3 indicators before and after surgery were significantly different (P all <0.01). Conclusion: Transurethral plasma-assisted laser ablation of benign prostatic hyperplasia is a safe and effective surgical method.